New app aims to give teens with suicidal thoughts a lifeline

NCT ID NCT06701006

Recruiting now Symptom relief Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing an app called Jaspr that helps teens and young adults with suicidal thoughts create a safety plan and learn coping skills. The app includes videos and tools for teens, parents, and healthcare providers. Researchers want to see if using the app improves how well teens cope, how confident parents feel, and how prepared providers are to help. The study will compare usual care alone to usual care plus the app in 60 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Jaspr app (digital safety planning and coping skills tool)
What this could lead to: If it works, this app could give teens and families practical tools to manage suicidal thoughts and improve communication with healthcare providers.
What could go wrong: This is a small early-stage study with only 60 participants, so results may not apply to everyone. The app is a support tool, not a replacement for professional care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDAL BEHAVIOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicidal Ideation Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUICIDAL BEHAVIOR SUICIDAL IDEATION

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Seattle Children's Hospital
RECRUITING

Seattle, Washington, 98115, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.